FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+7.15%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$9.59B
AUM Growth
+$9.59B
(+9%)
Cap. Flow
+$440M
Cap. Flow
% of AUM
4.59%
Top 10 Holdings %
Top 10 Hldgs %
52.56%
Holding
110
New
29
Increased
23
Reduced
18
Closed
24
Top Buys
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$175M |
| 2 |
TWX
Time Warner Inc
TWX
|
$148M |
| 3 |
NXP Semiconductors
NXPI
|
$147M |
| 4 |
Equifax
EFX
|
$137M |
| 5 |
TransUnion
TRU
|
$110M |
Top Sells
| 1 |
MBLY
Mobileye N.V.
MBLY
|
$371M |
| 2 |
SBA Communications
SBAC
|
$133M |
| 3 |
TMH
Team Health Holdings Inc
TMH
|
$105M |
| 4 |
ALR
Alere Inc
ALR
|
$84.1M |
| 5 |
Meta Platforms (Facebook)
META
|
$77.6M |
Sector Composition
| 1 | Technology | 27.68% |
| 2 | Communication Services | 23.4% |
| 3 | Healthcare | 14.67% |
| 4 | Industrials | 8.77% |
| 5 | Financials | 3.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AstraZeneca
AZN
$248B
| $108M | 0.96% | 3,180,000 +2,605,000 | +453% | +$88.3M |
|
27
AB InBev
BUD
$122B
| $107M | 0.95% | +900,000 | New | +$107M |
|
28
Liberty Global Class A
LBTYA
$4B
| $101M | 0.9% | 2,992,935 -1,227,169 | -29% | -$41.6M |
|
29
Liberty Global Class C
LBTYK
$4.07B
| $101M | 0.9% | 3,089,773 -1,263,163 | -29% | -$41.3M |
|
30
Huntsman Corp
HUN
$1.94B
| $96M | 0.85% | 3,500,000 -1,920,000 | -35% | -$52.6M |
|
|
CPN
31
DELISTED
Calpine Corporation
CPN
| $95.3M | 0.85% | +6,460,000 | New | +$95.3M |
|
32
Bristol-Myers Squibb
BMY
$96B
| $86.4M | 0.77% | +1,355,000 | New | +$86.4M |
|
33
Herbalife
HLF
$1.01B
| $85.5M | 0.76% | 1,259,835 -839,368 | -40% | -$56.9M |
|
34
Amicus Therapeutics
FOLD
$2.34B
| $76.6M | 0.68% | 5,081,055 +2,081,055 | +69% | +$31.4M |
|
35
Gilead Sciences
GILD
$140B
| $76.6M | 0.68% | +945,000 | New | +$76.6M |
|
|
AKRX
36
DELISTED
Akorn, Inc.
AKRX
| $75.7M | 0.67% | +2,280,000 | New | +$75.7M |
|
37
Charter Communications
CHTR
$36.3B
| $69.5M | 0.62% | 191,255 -143,570 | -43% | -$52.2M |
|
|
GNCMA
38
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $67.1M | 0.6% | 1,643,800 +1,004,824 | +157% | +$41M |
|
39
Comcast
CMCSA
$125B
| $67M | 0.6% | 1,741,621 -1,607,565 | -48% | -$61.9M |
|
|
BRCD
40
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $61.3M | 0.54% | +5,130,000 | New | +$61.3M |
|
41
FibroGen
FGEN
$47.8M
| $59.2M | 0.53% | 1,100,000 +28,000 | +3% | +$1.51M |
|
42
AbbVie
ABBV
$372B
| $52M | 0.46% | 585,000 -250,000 | -30% | -$22.2M |
|
43
Elevance Health
ELV
$71.8B
| $39.9M | 0.35% | 210,000 | – | – |
|
|
RC
44
Ready Capital
RC
$700M
| $36.5M | 0.32% | 2,324,236 | – | – |
|
|
XLRN
45
DELISTED
Acceleron Pharma Inc.
XLRN
| $35.9M | 0.32% | +963,000 | New | +$35.9M |
|
46
Grifois
GRFS
$6.78B
| $31.3M | 0.28% | 1,429,773 +349,899 | +32% | +$7.66M |
|
|
ESV
47
DELISTED
Ensco Rowan plc
ESV
| $29.4M | 0.26% | +4,920,000 | New | +$29.4M |
|
48
Exelixis
EXEL
$10.1B
| $28.8M | 0.26% | 1,190,000 -325,000 | -21% | -$7.87M |
|
49
Galapagos
GLPG
$2.07B
| $24M | 0.21% | +236,216 | New | +$24M |
|
50
Ionis Pharmaceuticals
IONS
$6.8B
| $22.8M | 0.2% | +450,000 | New | +$22.8M |
|